Citigroup’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $455M | Buy |
2,089,885
+438,228
| +27% | +$97.2M | 0.19% | 93 |
|
|
2025
Q4 | $377M | Sell |
1,651,657
-1,062,621
| -39% | -$242M | 0.17% | 100 |
|
|
2025
Q3 | $628M | Sell |
2,714,278
-581,584
| -18% | -$118M | 0.28% | 51 |
|
|
2025
Q2 | $612M | Buy |
3,295,862
+95,891
| +3% | +$17.8M | 0.3% | 56 |
|
|
2025
Q1 | $670M | Buy |
3,199,971
+753,198
| +31% | +$146M | 0.34% | 40 |
|
|
2024
Q4 | $435M | Buy |
2,446,773
+378,359
| +18% | +$69.6M | 0.26% | 65 |
|
|
2024
Q3 | $408M | Sell |
2,068,414
-303,143
| -13% | -$56.6M | 0.24% | 72 |
|
|
2024
Q2 | $407M | Buy |
2,371,557
+277,449
| +13% | +$46M | 0.26% | 67 |
|
|
2024
Q1 | $381M | Sell |
2,094,108
-205,907
| -9% | -$35.5M | 0.25% | 64 |
|
|
2023
Q4 | $356M | Sell |
2,300,015
-624,646
| -21% | -$91.1M | 0.25% | 63 |
|
|
2023
Q3 | $436M | Sell |
2,924,661
-443,329
| -13% | -$65.1M | 0.33% | 42 |
|
|
2023
Q2 | $454M | Buy |
3,367,990
+951,771
| +39% | +$140M | 0.3% | 44 |
|
|
2023
Q1 | $385M | Sell |
2,416,219
-758,551
| -24% | -$116M | 0.27% | 52 |
|
|
2022
Q4 | $513M | Buy |
3,174,770
+398,836
| +14% | +$61.2M | 0.41% | 31 |
|
|
2022
Q3 | $373M | Buy |
2,775,934
+141,461
| +5% | +$20.3M | 0.27% | 56 |
|
|
2022
Q2 | $403M | Buy |
2,634,473
+69,093
| +3% | +$10.6M | 0.3% | 45 |
|
|
2022
Q1 | $416M | Buy |
2,565,380
+118,156
| +5% | +$17.2M | 0.25% | 58 |
|
|
2021
Q4 | $331M | Sell |
2,447,224
-281,373
| -10% | -$33.2M | 0.18% | 95 |
|
|
2021
Q3 | $294M | Sell |
2,728,597
-125,277
| -4% | -$14.3M | 0.17% | 99 |
|
|
2021
Q2 | $321M | Sell |
2,853,874
-418,867
| -13% | -$47.2M | 0.19% | 89 |
|
|
2021
Q1 | $354M | Buy |
3,272,741
+255,207
| +8% | +$27.3M | 0.23% | 80 |
|
|
2020
Q4 | $323M | Buy |
3,017,534
+245,368
| +9% | +$23.6M | 0.19% | 90 |
|
|
2020
Q3 | $243M | Buy |
2,772,166
+199,268
| +8% | +$18.8M | 0.16% | 100 |
|
|
2020
Q2 | $253M | Sell |
2,572,898
-2,446,157
| -49% | -$215M | 0.2% | 81 |
|
|
2020
Q1 | $382M | Buy |
5,019,055
+483,669
| +11% | +$41.2M | 0.35% | 44 |
|
|
2019
Q4 | $402M | Buy |
4,535,386
+1,418,077
| +45% | +$118M | 0.29% | 52 |
|
|
2019
Q3 | $236M | Buy |
3,117,309
+1,763,534
| +130% | +$121M | 0.19% | 90 |
|
|
2019
Q2 | $98.4M | Buy |
1,353,775
+222,099
| +20% | +$17.5M | 0.08% | 236 |
|
|
2019
Q1 | $91.2M | Buy |
1,131,676
+442,120
| +64% | +$36.2M | 0.09% | 210 |
|
|
2018
Q4 | $63.6M | Sell |
689,556
-4,500
| -0.6% | -$396K | 0.06% | 307 |
|
|
2018
Q3 | $65.6M | Buy |
694,056
+6,187
| +0.9% | +$587K | 0.06% | 298 |
|
|
2018
Q2 | $63.7M | Sell |
687,869
-397,180
| -37% | -$38.8M | 0.06% | 284 |
|
|
2018
Q1 | $103M | Buy |
1,085,049
+142,038
| +15% | +$15.6M | 0.08% | 185 |
|
|
2017
Q4 | $91.2M | Sell |
943,011
-414,739
| -31% | -$39.1M | 0.07% | 240 |
|
|
2017
Q3 | $121M | Buy |
1,357,750
+183,195
| +16% | +$13.9M | 0.1% | 159 |
|
|
2017
Q2 | $85.2M | Buy |
1,174,555
+344,444
| +41% | +$23.2M | 0.08% | 197 |
|
|
2017
Q1 | $54.1M | Sell |
830,111
-159,857
| -16% | -$10.1M | 0.05% | 334 |
|
|
2016
Q4 | $62M | Buy |
989,968
+232,151
| +31% | +$14.2M | 0.06% | 318 |
|
|
2016
Q3 | $47.8M | Sell |
757,817
-347,094
| -31% | -$22.5M | 0.04% | 357 |
|
|
2016
Q2 | $68.4M | Buy |
1,104,911
+455,228
| +70% | +$27.7M | 0.07% | 268 |
|
|
2016
Q1 | $37.1M | Buy |
649,683
+41,885
| +7% | +$2.33M | 0.04% | 377 |
|
|
2015
Q4 | $36M | Sell |
607,798
-32,735
| -5% | -$1.89M | 0.04% | 474 |
|
|
2015
Q3 | $34.9M | Sell |
640,533
-2,123,442
| -77% | -$138M | 0.03% | 462 |
|
|
2015
Q2 | $186M | Buy |
2,763,975
+1,138,433
| +70% | +$74.3M | 0.16% | 84 |
|
|
2015
Q1 | $95.2M | Buy |
1,625,542
+311,997
| +24% | +$18.8M | 0.09% | 192 |
|
|
2014
Q4 | $86M | Buy |
1,313,545
+997,615
| +316% | +$62.9M | 0.08% | 250 |
|
|
2014
Q3 | $18.2M | Sell |
315,930
-477,219
| -60% | -$26.5M | 0.02% | 862 |
|
|
2014
Q2 | $44.8M | Buy |
793,149
+344,411
| +77% | +$18.1M | 0.04% | 395 |
|
|
2014
Q1 | $23.1M | Sell |
448,738
-268,913
| -37% | -$13.6M | 0.02% | 637 |
|
|
2013
Q4 | $37.9M | Sell |
717,651
-894,125
| -55% | -$43.9M | 0.03% | 477 |
|
|
2013
Q3 | $72.1M | Sell |
1,611,776
-292,969
| -15% | -$13M | 0.07% | 257 |
|
|
2013
Q2 | $78.7M | Buy |
+1,904,745
| New | +$83.3M | 0.08% | 197 |
|
Other funds holding ABBV
VCM
VPM
Citigroup's ABBV Position: Q1 2026 in Review
Citigroup increased its AbbVie (ABBV) stake by 27% in Q1 2026, buying an estimated $97.2M and bringing the position to 2,089,885 shares worth $455M. The position accounts for 0.19% of the portfolio, ranked #93.
Citigroup first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. The position peaked at $670M in Q1 2025. 4,076 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Citigroup held 2,089,885 shares of AbbVie worth $455M as of Q1 2026.
- Citigroup bought 438,228 AbbVie shares in Q1 2026, an estimated $97.2M.
- AbbVie made up 0.19% of Citigroup's portfolio in Q1 2026, its #93 holding.
- Citigroup first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- Citigroup's AbbVie position peaked at $670M in Q1 2025.
- 4,076 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.